Zacks: Analysts Anticipate Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share
Wall Street brokerages expect Dextera Surgical Inc. (NASDAQ:DXTR) to announce ($0.06) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Dextera Surgical’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Dextera Surgical posted earnings of ($0.44) per share during the same quarter last year, which indicates a positive year over year growth rate of 86.4%. The business is scheduled to announce its next quarterly earnings results on Monday, November 6th.
On average, analysts expect that Dextera Surgical will report full-year earnings of ($0.25) per share for the current fiscal year, with EPS estimates ranging from ($0.28) to ($0.20). For the next year, analysts anticipate that the firm will post earnings of ($0.20) per share, with EPS estimates ranging from ($0.20) to ($0.19). Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow Dextera Surgical.
Dextera Surgical (NASDAQ:DXTR) last released its quarterly earnings results on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.29). The company had revenue of $1.05 million during the quarter, compared to the consensus estimate of $1.03 million.
A number of equities analysts have weighed in on the company. Zacks Investment Research raised Dextera Surgical from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Ladenburg Thalmann Financial Services assumed coverage on Dextera Surgical in a research note on Wednesday, August 16th. They set a “buy” rating and a $0.80 price objective on the stock. Finally, Wedbush lowered their price objective on Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a research note on Wednesday, July 12th.
TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/10/11/zacks-analysts-anticipate-dextera-surgical-inc-dxtr-will-announce-earnings-of-0-06-per-share.html.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Perkins Capital Management Inc. acquired a new position in Dextera Surgical during the second quarter worth $100,000. Virtu KCG Holdings LLC boosted its stake in Dextera Surgical by 1,380.6% during the second quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock worth $111,000 after buying an additional 344,933 shares during the last quarter. Finally, Broadfin Capital LLC boosted its stake in Dextera Surgical by 64.7% during the second quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock worth $296,000 after buying an additional 388,080 shares during the last quarter. 6.58% of the stock is currently owned by institutional investors.
Shares of Dextera Surgical (NASDAQ DXTR) opened at 0.215 on Wednesday. The stock’s market cap is $3.83 million. The company’s 50-day moving average price is $0.30 and its 200 day moving average price is $0.41. Dextera Surgical has a 12-month low of $0.17 and a 12-month high of $2.33.
Dextera Surgical Company Profile
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.